Literature DB >> 27125213

Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.

Takuo Emoto1, Tomoya Yamashita2, Toshio Kobayashi3, Naoto Sasaki1, Yushi Hirota4, Tomohiro Hayashi1, Anna So4, Kazuyuki Kasahara1, Keiko Yodoi1, Takuya Matsumoto1, Taiji Mizoguchi1, Wataru Ogawa4, Ken-Ichi Hirata1.   

Abstract

The association between atherosclerosis and gut microbiota has been attracting increased attention. We previously demonstrated a possible link between gut microbiota and coronary artery disease. Our aim of this study was to clarify the gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism (T-RFLP). This study included 39 coronary artery disease (CAD) patients and 30 age- and sex- matched no-CAD controls (Ctrls) with coronary risk factors. Bacterial DNA was extracted from their fecal samples and analyzed by T-RFLP and data mining analysis using the classification and regression algorithm. Five additional CAD patients were newly recruited to confirm the reliability of this analysis. Data mining analysis could divide the composition of gut microbiota into 2 characteristic nodes. The CAD group was classified into 4 CAD pattern nodes (35/39 = 90 %), while the Ctrl group was classified into 3 Ctrl pattern nodes (28/30 = 93 %). Five additional CAD samples were applied to the same dividing model, which could validate the accuracy to predict the risk of CAD by data mining analysis. We could demonstrate that operational taxonomic unit 853 (OTU853), OTU657, and OTU990 were determined important both by the data mining method and by the usual statistical comparison. We classified the gut microbiota profiles in coronary artery disease patients using data mining analysis of T-RFLP data and demonstrated the possibility that gut microbiota is a diagnostic marker of suffering from CAD.

Entities:  

Keywords:  Coronary artery disease; Data mining analysis; Decision tree; Gut microbiota; Terminal restriction fragment length polymorphism (T-RFLP)

Mesh:

Substances:

Year:  2016        PMID: 27125213     DOI: 10.1007/s00380-016-0841-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Use of T-RFLP and seven restriction enzymes to compare the faecal microbiota of obese and lean Japanese healthy men.

Authors:  T Kobayashi; T Osaki; S Oikawa
Journal:  Benef Microbes       Date:  2015-06-03       Impact factor: 4.205

2.  Porphyromonas gingivalis promotes neointimal formation after arterial injury through toll-like receptor 2 signaling.

Authors:  Naho Kobayashi; Jun-ichi Suzuki; Masahito Ogawa; Norio Aoyama; Issei Komuro; Yuichi Izumi; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2013-09-04       Impact factor: 2.037

Review 3.  Adaptive Response of T and B Cells in Atherosclerosis.

Authors:  Daniel F J Ketelhuth; Göran K Hansson
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  The long-term stability of the human gut microbiota.

Authors:  Jeremiah J Faith; Janaki L Guruge; Mark Charbonneau; Sathish Subramanian; Henning Seedorf; Andrew L Goodman; Jose C Clemente; Rob Knight; Andrew C Heath; Rudolph L Leibel; Michael Rosenbaum; Jeffrey I Gordon
Journal:  Science       Date:  2013-07-05       Impact factor: 47.728

5.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

6.  Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

Authors:  Naoto Sasaki; Tomoya Yamashita; Masafumi Takeda; Masakazu Shinohara; Kenji Nakajima; Hideto Tawa; Takashi Usui; Ken-Ichi Hirata
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

Review 7.  Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases.

Authors:  Tomoya Yamashita; Kazuyuki Kasahara; Takuo Emoto; Takuya Matsumoto; Taiji Mizoguchi; Naoki Kitano; Naoto Sasaki; Ken-Ichi Hirata
Journal:  Circ J       Date:  2015-07-22       Impact factor: 2.993

8.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

9.  Applying Data Mining to Classify Age by Intestinal Microbiota in 92 Healthy Men Using a Combination of Several Restriction Enzymes for T-RFLP Experiments.

Authors:  Toshio Kobayashi; Takako Osaki; Shinya Oikawa
Journal:  Biosci Microbiota Food Health       Date:  2014-04-29

10.  Identification of Heavy Smokers through Their Intestinal Microbiota by Data Mining Analysis.

Authors:  Toshio Kobayashi; Kenji Fujiwara
Journal:  Biosci Microbiota Food Health       Date:  2013-04-27
View more
  45 in total

1.  Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.

Authors:  Taiji Mizoguchi; Kazuyuki Kasahara; Tomoya Yamashita; Naoto Sasaki; Keiko Yodoi; Takuya Matsumoto; Takuo Emoto; Tomohiro Hayashi; Naoki Kitano; Naofumi Yoshida; Hilman Zulkifli Amin; Ken-Ichi Hirata
Journal:  Heart Vessels       Date:  2017-02-08       Impact factor: 2.037

Review 2.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

Review 3.  Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.

Authors:  Klytaimnistra Kiouptsi; Christoph Reinhardt
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

4.  Human Oral Buccal Microbiomes Are Associated with Farmworker Status and Azinphos-Methyl Agricultural Pesticide Exposure.

Authors:  Ian B Stanaway; James C Wallace; Ali Shojaie; William C Griffith; Sungwoo Hong; Carly S Wilder; Foad H Green; Jesse Tsai; Misty Knight; Tomomi Workman; Eric M Vigoren; Jeffrey S McLean; Beti Thompson; Elaine M Faustman
Journal:  Appl Environ Microbiol       Date:  2016-12-30       Impact factor: 4.792

Review 5.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

Review 6.  Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.

Authors:  Francesco Violi; Vittoria Cammisotto; Simona Bartimoccia; Pasquale Pignatelli; Roberto Carnevale; Cristina Nocella
Journal:  Nat Rev Cardiol       Date:  2022-07-15       Impact factor: 49.421

7.  Comparative analysis of the gut microbiota composition in the Cln1R151X and Cln2R207X mouse models of Batten disease and in three wild-type mouse strains.

Authors:  Camille Parker; Jing Zhao; David A Pearce; Attila D Kovács
Journal:  Arch Microbiol       Date:  2020-08-04       Impact factor: 2.552

8.  Microbiome and metabonomics study of quercetin for the treatment of atherosclerosis.

Authors:  Dong-Ning Wu; Le Guan; Yi-Xin Jiang; Su-Hua Ma; Ya-Nan Sun; Hong-Tao Lei; Wei-Feng Yang; Qing-Feng Wang
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

Review 9.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

10.  Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.

Authors:  Lidia Sanchez-Alcoholado; Daniel Castellano-Castillo; Laura Jordán-Martínez; Isabel Moreno-Indias; Pilar Cardila-Cruz; Daniel Elena; Antonio J Muñoz-Garcia; Maria I Queipo-Ortuño; Manuel Jimenez-Navarro
Journal:  Front Microbiol       Date:  2017-10-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.